Mishra S, Santana J, Mihailovic J, Hyder F, Coman D
NMR Biomed. 2024; 37(5):e5102.
PMID: 38263680
PMC: 10987279.
DOI: 10.1002/nbm.5102.
Calatayud D, Lledos M, Casarsa F, Pascu S
ACS Bio Med Chem Au. 2023; 3(5):389-417.
PMID: 37876497
PMC: 10591303.
DOI: 10.1021/acsbiomedchemau.3c00021.
Subasinghe S, Ortiz C, Romero J, Ward C, Sertage A, Kurenbekova L
Proc Natl Acad Sci U S A. 2023; 120(15):e2220891120.
PMID: 37018203
PMC: 10104500.
DOI: 10.1073/pnas.2220891120.
Lutter J, Batchev A, Ortiz C, Sertage A, Romero J, Subasinghe S
Adv Healthc Mater. 2023; 12(19):e2203209.
PMID: 36906514
PMC: 10440236.
DOI: 10.1002/adhm.202203209.
Subasinghe S, Pautler R, Hassan Samee M, Yustein J, Allen M
Biosensors (Basel). 2022; 12(7).
PMID: 35884281
PMC: 9313010.
DOI: 10.3390/bios12070478.
Radiometal-Based PET/MRI Contrast Agents for Sensing Tumor Extracellular pH.
Pollard A, de la Cerda J, Schuler F, Pollard T, Kotrotsou A, Pisaneschi F
Biosensors (Basel). 2022; 12(2).
PMID: 35200394
PMC: 8870419.
DOI: 10.3390/bios12020134.
Targeted PET/MRI Imaging Super Probes: A Critical Review of Opportunities and Challenges.
Kastelik-Hryniewiecka A, Jewula P, Bakalorz K, Kramer-Marek G, Kuznik N
Int J Nanomedicine. 2022; 16:8465-8483.
PMID: 35002239
PMC: 8733213.
DOI: 10.2147/IJN.S336299.
Towards Photoswitchable Contrast Agents for Absolute 3D Temperature MR Imaging.
Wellm V, Groebner J, Heitmann G, Sonnichsen F, Herges R
Angew Chem Int Ed Engl. 2021; 60(15):8220-8226.
PMID: 33606332
PMC: 8048480.
DOI: 10.1002/anie.202015851.
From Zn(II) to Cu(II) Detection by MRI Using Metal-Based Probes: Current Progress and Challenges.
Malikidogo K, Martin H, Bonnet C
Pharmaceuticals (Basel). 2020; 13(12).
PMID: 33266014
PMC: 7760112.
DOI: 10.3390/ph13120436.
Microenvironment Stimulated Bioresponsive Small Molecule Carriers for Radiopharmaceuticals.
Chaturvedi S, Hazari P, Kaul A, Anju , Mishra A
ACS Omega. 2020; 5(41):26297-26306.
PMID: 33110957
PMC: 7581084.
DOI: 10.1021/acsomega.0c03601.
Dealing with PET radiometabolites.
Ghosh K, Padmanabhan P, Yang C, Mishra S, Halldin C, Gulyas B
EJNMMI Res. 2020; 10(1):109.
PMID: 32997213
PMC: 7770856.
DOI: 10.1186/s13550-020-00692-4.
Whole-Body Atherosclerosis Imaging by Positron Emission Tomography/Magnetic Resonance Imaging: From Mice to Nonhuman Primates.
Calcagno C, Perez-Medina C, Mulder W, Fayad Z
Arterioscler Thromb Vasc Biol. 2020; 40(5):1123-1134.
PMID: 32237905
PMC: 7458122.
DOI: 10.1161/ATVBAHA.119.313629.
Self-Immolative Activation of β-Galactosidase-Responsive Probes for In Vivo MR Imaging in Mouse Models.
Lilley L, Kamper S, Caldwell M, Chia Z, Ballweg D, Vistain L
Angew Chem Int Ed Engl. 2019; 59(1):388-394.
PMID: 31750611
PMC: 6923588.
DOI: 10.1002/anie.201909933.
Molecular Magnetic Resonance Imaging with Gd(III)-Based Contrast Agents: Challenges and Key Advances.
Li H, Meade T
J Am Chem Soc. 2019; 141(43):17025-17041.
PMID: 31593630
PMC: 6821590.
DOI: 10.1021/jacs.9b09149.
Manganese in PET imaging: Opportunities and challenges.
Brandt M, Cardinale J, Rausch I, Mindt T
J Labelled Comp Radiopharm. 2019; 62(8):541-551.
PMID: 31115089
PMC: 6771670.
DOI: 10.1002/jlcr.3754.
PET-MR and SPECT-MR multimodality probes: Development and challenges.
Yang C, Ghosh K, Padmanabhan P, Langer O, Liu J, Eng D
Theranostics. 2019; 8(22):6210-6232.
PMID: 30613293
PMC: 6299694.
DOI: 10.7150/thno.26610.
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.
Wahsner J, Gale E, Rodriguez-Rodriguez A, Caravan P
Chem Rev. 2018; 119(2):957-1057.
PMID: 30350585
PMC: 6516866.
DOI: 10.1021/acs.chemrev.8b00363.
Towards Ni(II) complexes with spin switches for F MR-based pH sensing.
Xie D, Ohman L, Que E
MAGMA. 2018; 32(1):89-96.
PMID: 30178207
DOI: 10.1007/s10334-018-0698-4.
Synthesis, Radiolabelling and In Vitro Imaging of Multifunctional Nanoceramics.
Lledos M, Mirabello V, Sarpaki S, Ge H, Smugowski H, Carroll L
ChemNanoMat. 2018; 4(4):361-372.
PMID: 29938196
PMC: 5993288.
DOI: 10.1002/cnma.201700378.
New horizons in multimodality molecular imaging and novel radiotracers.
Barrington S, Blower P, Cook G
Clin Med (Lond). 2017; 17(5):444-448.
PMID: 28974596
PMC: 6301925.
DOI: 10.7861/clinmedicine.17-5-444.